0 Comments
0 Shares
78 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Synthetic Biology Market Forecast Based on Growing Demand for Precision MedicineThe global Synthetic Biology Market was valued at USD 18.9 billion in 2025 and is projected to grow from USD 22.1 billion in 2026 to USD 69.2 billion by 2033, registering a robust CAGR of 17.7% from 2026 to 2033. The market is witnessing significant expansion as advances in genetic engineering, genome editing, and biological system design continue to unlock new opportunities across...0 Comments 0 Shares 86 Views 0 Reviews
-
Synthetic Biology Market Forecast Based on Growing Demand for Precision MedicineThe global Synthetic Biology Market was valued at USD 18.9 billion in 2025 and is projected to grow from USD 22.1 billion in 2026 to USD 69.2 billion by 2033, registering a robust CAGR of 17.7% from 2026 to 2033. The market is witnessing significant expansion as advances in genetic engineering, genome editing, and biological system design continue to unlock new opportunities across...0 Comments 0 Shares 123 Views 0 Reviews
-
The Future of Precision Medicine in the Clinical Data Analytics Solutions MarketThe global clinical data analytics solutions market size was estimated at USD 5.4 billion in 2025 and is projected to reach USD 9.0 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. The market is witnessing strong expansion due to rapid advancements in artificial intelligence (AI), machine learning (ML), cloud computing, and healthcare digitization technologies. ...0 Comments 0 Shares 87 Views 0 Reviews
-
Esoteric Testing Market Size to Surpass USD 74.78 Billion by 2033 Driven by Precision Medicine and Advanced DiagnosticsThe global Esoteric Testing Market is witnessing rapid expansion, fueled by increasing demand for advanced diagnostic solutions and the growing prevalence of chronic and infectious diseases. According to Straits Research, the market size was valued at USD 28.8 billion in 2024 and is projected to grow from USD 32.03 billion in 2025 to USD 74.78 billion by 2033, registering a robust...0 Comments 0 Shares 160 Views 0 Reviews
-
Multiplex Assays Market Outlook: Increasing Adoption in Precision MedicineMultiplex Immunoassay: Advancing Precision Diagnostics in the Growing Multiplex Assays Market The multiplex immunoassay is a highly advanced laboratory technique that enables the simultaneous detection and quantification of multiple biomarkers within a single biological sample. This powerful diagnostic approach has transformed biomedical research, clinical diagnostics, and drug discovery...0 Comments 0 Shares 39 Views 0 Reviews
-
Red Biotechnology Market Set to Surpass USD 1.45 Trillion by 2033 Amid Surge in Precision Medicine and Biologics InnovationThe global red biotechnology market continues its strong growth trajectory, with its valuation projected to rise from USD 606.1 billion in 2024 to USD 1,452.71 billion by 2033, registering a robust CAGR of 10.2% during the forecast period (2025–2033). The market’s expansion is fueled by increasing demand for advanced therapeutics, a growing pipeline of biologics, and rising...0 Comments 0 Shares 187 Views 0 Reviews
-
Blood-Based Biomarker for Alzheimer's Disease Diagnostics Market Demand for Early Cognitive Disorder ScreeningThe global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in 2026 to USD 529.9 million by 2033, registering a CAGR of 17.4% from 2026 to 2033. North America dominated the global market with a 43.0% revenue share in 2025, driven by regulatory approvals, expanding clinical...0 Comments 0 Shares 68 Views 0 Reviews
-
Rare Disease Genetic Testing Market Trends in Prenatal and Newborn ScreeningThe global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...0 Comments 0 Shares 48 Views 0 Reviews
